Australia markets closed

Zhejiang Wecome Pharmaceutical Company Limited (300878.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
14.85+0.49 (+3.41%)
At close: 03:04PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
523,835
519,621
532,442
632,953
622,767
Cost of revenue
253,696
257,763
219,081
204,376
171,419
Gross profit
270,139
261,858
313,361
428,577
451,348
Operating expenses
Research development
36,928
42,798
39,320
37,015
20,409
Selling general and administrative
230,888
216,400
199,962
276,465
279,970
Total operating expenses
296,684
284,460
251,810
324,302
289,504
Operating income or loss
-26,545
-22,602
61,551
104,275
161,843
Interest expense
9,362
9,450
5,410
2,159
253.3572
Income before tax
-12,067
-5,786
63,149
100,028
158,702
Income tax expense
-2,254
398.5927
13,667
3,481
22,997
Income from continuing operations
-9,813
-6,184
49,482
96,547
135,704
Net income
-11,230
-8,039
48,810
96,495
135,816
Net income available to common shareholders
-11,230
-8,039
48,810
96,495
135,816
Basic EPS
0.14
-0.06
0.34
0.67
1.13
Diluted EPS
0.14
-0.06
0.34
0.67
1.13
Basic average shares
143,356
133,976
143,560
144,023
120,428
Diluted average shares
143,356
133,976
143,560
144,023
120,428